Anuh Pharma, a totally debt free company is slightly over priced. It can well be bought at Rs.200 though those who are are invest in this company for period extending 6 - 12 months can buy at current price too.
It has the market cap of Rs.958 with higher price to earning of 37 against the industry price to earning of 30. With EPS of 06, it pays the dividend of 140% with FV of Rs.5/-. Small equity capital at 4 crore, it has growing reserves of over 95 crore. Valuations as on 31 Mar 2015 were very good with profit generating efficiency level of more than 30%.
Management of Anuh Pharma is adding to its capacity utilization to 80% from current capacity utilization of 65% with revenue growth targetted at 25% on the higher side. It is also adding four news products to its existing inventory for the year 2016.
In the past Anuh Pharma has very decently rewarded to its share holders when it comes to rise in price. One should buy this stock for med to long term.